Skip to content
  • HOME
  • HIGHLIGHTS
  • COMPANY
  • PRESENTATION
  • NEWS
  • CONTACT

October 16, 2025

Ocumetics Webinar Replay: First-In-Human Study One-Month Postoperative Results Update (Oct 15, 2025)

Ocumetics Webinar Replay: First-In-Human Study One-Month Postoperative Results Update (Oct 15, 2025)

  • Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update

    Calgary, Alberta – February 10, 2026 – TheNewswire – Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that the Corporation has entered into a forbearance agreement with the holders of secured convertible debentures (the “Debentures”) that were issued by the Corporation in May and June 2024 (see press release

    Continue reading
  • Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

    Continue reading
  • Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

    Calgary, AB – TheNewswire – January 2, 2026 – Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) is pleased to announce that it has closed the first tranche of its previously announced best efforts brokered private placement of units of the Company (the “Units”) for aggregate gross proceeds of approximately

    Continue reading
  • Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital

    Calgary, AB – TheNewswire – December 19, 2025 – Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) announces that further to its previously announced (November 25, 2025) brokered private placement (the “Offering”) on a best-efforts basis led by Centurion One Capital Corp. (the “Lead Agent”), the Corporation has amended the

    Continue reading
Previous234Next

TSX-V:OTC | OCTQB: OTCFF | FSE: 2QB0

Contact Information

#1250 – 639 5th Ave SW
Calgary AB T2P 0M9
Canada

Investor Relations

Vice President – Howard Group Inc
Dave Burwell – Send Email

© 2026 • Powered by Howard Group • Privacy Policy • Ocumetics Technology Corp
Page load link
Go to Top